Prevalence of and racial disparities in risk factor control in older adults with diabetes: The atherosclerosis risk in communities study

Diabetes Care

Volumn 38, Issue 7, 2015, Pages 1290-1298

  Parrinello, Christina M ^a   Rastegar, Ina ^a,b   Godino, Job G ^a,c   Miedema, Michael D ^d   Matsushita, Kunihiro ^a   Selvin, Elizabeth ^a,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Baltimore Polytechnic Institute   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; ATHEROSCLEROSIS; BLACK PERSON; BLOOD PRESSURE REGULATION; CAUCASIAN; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE CONTROL; DRUG INDICATION; ETHNICITY; FEMALE; GLYCEMIC CONTROL; HUMAN; MALE; PREVALENCE; RISK ASSESSMENT; VERY ELDERLY; AFRICAN AMERICAN; BLOOD PRESSURE; CLINICAL TRIAL; DIABETIC ANGIOPATHIES; EPIDEMIOLOGY; ETHNOLOGY; METABOLISM; MULTICENTER STUDY; PHYSIOLOGY; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL, LDL; DIABETIC ANGIOPATHIES; EPIDEMIOLOGIC METHODS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; UNITED STATES;

EID: 84941419328     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0016     Document Type: Article

References (51)

1. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012;35:2650-2664
2. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014;160:517-525
3. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA, U.S. Department of Health and Human Services, 2014
4. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 2011;154:554-559
5. Turnbull FM, Abraira C, Anderson RJ, et al, .; Control Group. Intensive glucose control and macrovascular outcomes in type 2 diabetes [published correction appears in Diabetologia 2009;52:2470]. Diabetologia 2009;52:2288-2298
6. Inzucchi SE, Bergenstal RM, Buse JB, et al, .; American Diabetes Association (ADA), ; European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379
7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
9. Buse JB, Ginsberg HN, Bakris GL, et al, .; American Heart Association, ; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30:162-172
10. Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-591
11. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
12. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36:2271-2279
13. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342
14. Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med 2014;161:681-689
15. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624
16. Chatterji P, Joo H, Lahiri K. Racial/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes. Diabetes Care 2012;35:305-312
17. Egede LE, Gebregziabher M, Lynch CP, Gilbert GE, Echols C. Longitudinal ethnic differences in multiple cardiovascular risk factor control in a cohort of US adults with diabetes. Diabetes Res Clin Pract 2011;94:385-394
18. Holland AT, Zhao B, Wong EC, Choi SE, Wong ND, Palaniappan LP. Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population. J Diabetes Complications 2013;27:34-40
19. Moreno G, Mangione CM. Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review. J Am Geriatr Soc 2013;61:2027-2037
20. Moghissi E. Management of type 2 diabetes mellitus in older patients: current and emerging treatment options. Diabetes Ther 2013;4:239-256
21. Centers for Disease Control and Prevention. Diabetes Public Health Resource. Emergency department visit rates for hypoglycemia as first-listed diagnosis per 1,000 diabetic adults aged 18 years or older, by age, United States, 2006-2009, 2012. Available from http://www.cdc.gov/diabetes/statistics/hypoglycemia/fig5byage.htm. Accessed 16 October 2014
22. Gerstein HC, Miller ME, Byington RP, et al, .; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
23. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 2014;174:251-258
24. Zoungas S, Patel A, Chalmers J, et al, .; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418
25. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36:1384-1395
26. Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014;174:1116-1124
27. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702
28. Schneider ALC, Pankow JS, Heiss G, Selvin E. Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiol 2012;176:738-743
29. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-942
30. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556-561
31. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000;55:M221-M231
32. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-M94
33. Kuo HK, Bean JF, Yen CJ, Leveille SG. Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J Gerontol A Biol Sci Med Sci 2006;61:380-387
34. Kuo H-K, Leveille SG, Yen C-J, et al. Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the National Health and Nutrition Examination Survey (NHANES), 1999-2002. Am J Phys Med Rehabil 2006;85:650-658
35. Chen H, Guo X. Obesity and functional disability in elderly Americans. J Am Geriatr Soc 2008;56:689-694
36. Kalyani RR, Saudek CD, Brancati FL, Selvin E. Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care 2010;33:1055-1060
37. Levey AS, Stevens LA, Schmid CH, et al, .; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
38. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-520
39. Moreno G, Mangione CM, Kimbro L, Vaisberg E; American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc 2013;61:2020-2026
40. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
41. Wang Y, Katzmarzyk PT, Horswell R, et al. Racial disparities in cardiovascular risk factor control in an underinsured population with type 2 diabetes. Diabet Med 2014;31:1230-1236
42. Bertoni AG, Clark JM, Feeney P, et al, .; Look AHEAD Research Group. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications 2008;22:1-9
43. Ayanian JZ, Landon BE, Newhouse JP, Zaslavsky AM. Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med 2014;371:2288-2297
44. Vimalananda VG, Miller DR, Palnati M, Christiansen CL, Fincke BG. Gender disparities in lipid-lowering therapy among veterans with diabetes. Womens Health Issues 2011;21(Suppl.):S176-S181
45. Strom Williams JL, Lynch CP, Winchester R, Thomas L, Keith B, Egede LE. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes. Diabetes Technol Ther 2014;16:421-427
46. Imran SA, Rabasa-Lhoret R, Ross S. Targets for glycemic control. Can J Diabetes 2013;37(Suppl. 1):S31-S34
47. Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med 2014;174:1227-1234
48. Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med 2010;170:1037-1044
49. Laiteerapong N, Fairchild PC, Chou CH, Chin MH, Huang ES. Revisiting disparities in quality of care among US adults with diabetes in the era of individualized care, NHANES 2007-2010. Med Care 2015;53:25-31
50. Selvin E, Parrinello CM. Age-related differences in glycaemic control in diabetes. Diabetologia 2013;56:2549-2551
51. Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006;29:2415-2419